Bringing together the leaders in cancer early detection

The Early Detection of Cancer Conference is part of a long-term commitment to invest in early detection, to understand the biology behind early stage cancers, find new detection and screening...

Helping more bladder cancer patients preserve a functioning bladder

Knight Cancer clinicians at Tuality/OHSU Cancer Center are the first in Oregon to offer a treatment option that will improve outcomes for patients with bladder cancer who cannot tolerate surgery or...

Cancer cell fusion study showcased in Science

Cell fusion is one of the ways that tumors can gain abilities to become life-threatening and resist treatment, Melissa Wong, Ph.D., and colleagues first reported last year. The paper now is one of...

Targeting osteosarcoma, a cancer more common in young people

Knight Cancer researchers describe positive results with the drug regorafenib. Osteosarcoma is a bone cancer that disproportionately affects teenagers, and despite substantial efforts, outcomes for...

Should health plans cover fertility preservation for cancer patients?

Young adults undergoing toxic therapies for cancer have highly effective options to preserve fertility. But the great cost – easily $15,000 or more for a woman – puts the option out of the reach...

Eleven inspired projects underway with Knight Cancer pilot funds

Exploring immune therapy combinations to stop aggressive breast cancers. Unraveling the gene changes that make juvenile myelomonocytic leukemia so difficult-to-treat. Developing a biomarker to guide...

Long after childbirth, a persistent risk for metastatic breast cancer

Breast cancers that emerge after a woman gives birth are significantly more likely to spread and become life-threatening. And this elevated risk endures for at least 10 years, a new study has...